Nocturnal hypertension is an important predictor of the progression of left ventricular diastolic dysfunction in patients with diabetes without HF. An important predictor for the progression of left ...

Patients with severe left ventricular dysfunction undergoing TAVI for aortic stenosis who experience an improvement in their ventricle’s function achieve mid-term mortality similar to that seen among ...

Vancouver, BC - The PET and Recovery Following Revascularization (PARR-2) trial showed that, among patients with severe left ventricular (LV) dysfunction, those who received fluorodeoxyglucose (FDG) ...

PCI doesn’t reduce arrhythmia risks in patients with severe LV dysfunction and extensive coronary disease, according to a prespecified analysis of the REVIVED-BCIS2 trial. The results call into ...

Please provide your email address to receive an email when new articles are posted on . Subclinical left ventricular abnormalities in SSc impact survival and increase dyspnea risk. LV ejection ...

Severe hypothyroidism is associated with a high burden of systolic/diastolic ventricular dysfunction and myocardial ...

Women with peripartum cardiomyopathy (PPCM), regardless of whether their left ventricular (LV) function recovers, may have a heightened risk for a relapse and other cardiovascular events if they ...

High levels of inflammatory biomarkers are associated with a higher incidence of acute heart failure (HF), increased risk of readmission, and higher mortality. 1 There is also a strong correlation ...

Researchers from Edgewise Therapeutics Inc. presented preclinical data for the cardiac sarcomere modulator, EDG-7500, which is being developed for the treatment of hypertrophic cardiomyopathy (HCM) ...